Stay updated on Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial
Sign up to get notified when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.

Latest updates to the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page footer now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This update reflects a maintenance release and does not alter the study details or user-facing navigation.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision indicator updated to v3.6.5, replacing the previous v3.6.4. This represents a minor version update for the page rather than substantive content changes to the study details.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small update to the page's version metadata rather than substantive content changes.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates an update to the page version and metadata.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page's software revision tag was updated from v3.6.0 to v3.6.2, indicating a deployment or patch to the site's underlying platform rather than a change to the study details.SummaryDifference0.1%

- Check85 days agoChange DetectedNew reader guidance sections and a recruitment-status note were added to the study page, along with a minor formatting adjustment to the Intervention/Treatment label.SummaryDifference0.5%

Stay in the know with updates to Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.